Connect with us

Business

ASX to rise; workplace culture, climate change in focus – Yahoo Finance Australia

Here’s Yahoo Finance’s Friday morning wrap.

Published

on

Article feature image

Mesoblast Operational and Financial Highlights for Quarter Ended March 31, 2021NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the third quarter ended March 31, 2021. We are very excited about the top-line results announced today from the trial of remestemcel-L in patients on mechanical…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending